Migraine. Migraine
Conditions
Interventions
Intervention 1: Migraine patients: Use of MigraineCut nasal spray containing extract of herbs intended to reduce headaches indices and clinical signs of migraine within 120 days at an authorized dose
Sponsors
MIMDaroo Pharmaceutical Co.
Eligibility
Sex/Gender
All
Age
16 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patient with migraine after being diagnosed by a neurologist. Male or female patient has a migraine attack at least one month per year. Patient aged between 16 and 60 years who has the opportunity to complete the diary form and communicate effectively with the counselor. Patient that doesn't have susceptibility to herbal medicines.
Exclusion criteria
Exclusion criteria: Patient with probable migraine headaches Patients with medication overused headaches Patients with complex headaches Patients who provide incomplete data and information to the counselor. Patients who do not wish to start or continue treatment with knowledge of the conditions of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headeches frequency. Timepoint: Counting the number of headaches from the beginning of the study (before the intervention), 30, 60, 90, and 120 days after the start of the MigraineCut. Method of measurement: headache diary form.;Headache intensity. Timepoint: Record the intensity of each migraine attack every month for up to 4 months during the study. Method of measurement: Headache diray form.;Headache duration. Timepoint: Calculate the duration of headaches before the intervention, and during 30, 60, 90, and 120 days from the onset of intervention with cutaneous migraine. Method of measurement: Headache diray form. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the clinical symptoms of migraineurs. Timepoint: Clinical symptoms of patients, such as sensitivity to light and sound before intervention, and 30, 60, 90, and 120 days after intervention are investigated. Method of measurement: Headache diary form and expert visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarid Semsarha
MIMDaroo Pharmaceutical Co.
Outcome results
None listed